bs-4979R [Primary Antibody]
eIF4E Polyclonal Antibody
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: eIF4E

Immunogen Range: 121-217/217


Clonality: Polyclonal

Isotype: IgG

Entrez Gene: 1977

Swiss Prot: P06730

Source: KLH conjugated synthetic peptide derived from human eIF4E

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Background:

Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit mediates the binding to the mRNA cap.

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)
ELISA(1:500-1000)
IHC-P(1:200-400)
IHC-F(1:100-500)
IF(IHC-P)(1:50-200)
IF(IHC-F)(1:50-200)
IF(ICC)(1:50-200)
ICC(1:100-500)

Predicted Molecular Weight: 24


Cross Reactive Species: Human
Rat

Predicted Cross Reactive Species: Mouse

For research use only. Not intended for diagnostic or therapeutic use.

VALIDATION IMAGES

Image provided by One World Lab validation program. A431 cells probed with Rabbit Anti-eIF4E Polyclonal Antibody (bs-4979R) at 1:50 for 60 minutes at room temperature followed by Goat Anti-Rabbit IgG (H+L) Alexa Fluor 488 Conjugated secondary antibody.


Image provided by the Independent Validation Program, badge number 029640:Formalin-fixed and paraffin embedded human pancreas labeled with Anti-eIF4E Polyclonal Antibody, Unconjugated (bs-4979R) at 1:250 followed by conjugation to the secondary antibody and DAB staining


Lane 1: Mouse Colon lysates; Lane 2: Rat Colon lysates probed with eIF4E Polyclonal Antibody, Unconjugated (bs-4979R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.